Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?

In clinical practice, we need to develop new tools to identify the residual cardiovascular risk after acute coronary syndrome (ACS). This study aimed to evaluate whether the monocyte to high-density lipoprotein cholesterol ratio (MHR) variation (ΔMHR) obtained during hospital admission (MHR1) and re...

Full description

Bibliographic Details
Main Authors: E.T. Figueiredo, C.H. Miranda
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2023-01-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100685&tlng=en
_version_ 1797957098890330112
author E.T. Figueiredo
C.H. Miranda
author_facet E.T. Figueiredo
C.H. Miranda
author_sort E.T. Figueiredo
collection DOAJ
description In clinical practice, we need to develop new tools to identify the residual cardiovascular risk after acute coronary syndrome (ACS). This study aimed to evaluate whether the monocyte to high-density lipoprotein cholesterol ratio (MHR) variation (ΔMHR) obtained during hospital admission (MHR1) and repeated in the first outpatient evaluation (MHR2) is a predictor of major adverse cardiovascular events (MACE) after ACS. One hundred ninety-one patients admitted for ACS were prospectively included. The ΔMHR was calculated by subtracting MHR1 from MHR2. Patients were followed for 166±38 days in which the occurrence of MACE was observed. The best cutoff for ΔMHR was zero (0), and individuals were divided into two groups: ΔMHR<0 (n=113) and ΔMHR≥0 (n=78). The presence of MACE was higher in the ΔMHR≥0 (22%) than in the ΔMHR<0 (7%), with a hazard ratio (HR) of 3.96 (95% confidence interval [CI]: 1.74-8.99; P=0.0004). After adjusting for confounders, ΔMHR≥0 remained an independent MACE predictor with an adjusted HR of 3.13 (95%CI: 1.35-7.26, P=0.008). In conclusion, our study showed that ΔMHR was an independent MACE predictor after ACS. Thus, ΔMHR is a potential marker of residual cardiovascular risk after ACS.
first_indexed 2024-04-10T23:59:02Z
format Article
id doaj.art-822a7687f4f54d488afef42b30c7c376
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-04-10T23:59:02Z
publishDate 2023-01-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-822a7687f4f54d488afef42b30c7c3762023-01-10T07:33:26ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2023-01-015510.1590/1414-431x2022e12410Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?E.T. Figueiredohttps://orcid.org/0000-0002-8293-8611C.H. Mirandahttps://orcid.org/0000-0002-5968-4879In clinical practice, we need to develop new tools to identify the residual cardiovascular risk after acute coronary syndrome (ACS). This study aimed to evaluate whether the monocyte to high-density lipoprotein cholesterol ratio (MHR) variation (ΔMHR) obtained during hospital admission (MHR1) and repeated in the first outpatient evaluation (MHR2) is a predictor of major adverse cardiovascular events (MACE) after ACS. One hundred ninety-one patients admitted for ACS were prospectively included. The ΔMHR was calculated by subtracting MHR1 from MHR2. Patients were followed for 166±38 days in which the occurrence of MACE was observed. The best cutoff for ΔMHR was zero (0), and individuals were divided into two groups: ΔMHR<0 (n=113) and ΔMHR≥0 (n=78). The presence of MACE was higher in the ΔMHR≥0 (22%) than in the ΔMHR<0 (7%), with a hazard ratio (HR) of 3.96 (95% confidence interval [CI]: 1.74-8.99; P=0.0004). After adjusting for confounders, ΔMHR≥0 remained an independent MACE predictor with an adjusted HR of 3.13 (95%CI: 1.35-7.26, P=0.008). In conclusion, our study showed that ΔMHR was an independent MACE predictor after ACS. Thus, ΔMHR is a potential marker of residual cardiovascular risk after ACS.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100685&tlng=enMonocyte to high-density lipoprotein cholesterol ratioCoronary artery diseaseAcute myocardial infarctionUnstable anginaMajor cardiovascular events
spellingShingle E.T. Figueiredo
C.H. Miranda
Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
Brazilian Journal of Medical and Biological Research
Monocyte to high-density lipoprotein cholesterol ratio
Coronary artery disease
Acute myocardial infarction
Unstable angina
Major cardiovascular events
title Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
title_full Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
title_fullStr Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
title_full_unstemmed Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
title_short Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome?
title_sort is the variation in monocyte to high density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome
topic Monocyte to high-density lipoprotein cholesterol ratio
Coronary artery disease
Acute myocardial infarction
Unstable angina
Major cardiovascular events
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2022000100685&tlng=en
work_keys_str_mv AT etfigueiredo isthevariationinmonocytetohighdensitylipoproteincholesterolratioapredictorofmajorcardiovasculareventsafteracutecoronarysyndrome
AT chmiranda isthevariationinmonocytetohighdensitylipoproteincholesterolratioapredictorofmajorcardiovasculareventsafteracutecoronarysyndrome